Pu et al. reported that downregulation of Wnt2 suppresses malignant glioma cell growth associated with decreased activation of the of PI3K/AKT signaling pathway [36], which affects cell growth and survival through modulation of mammalian target of Rapamycin (mTOR) signaling [40]. The gene discussed is MTOR; the disease is malignant glioma.